Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CNS-PHLAT: Thiotepa-based ASCT for CNS-Relapse Prevention in High-Risk DLBCL
NCT06687772Phase 2Recruiting
- Sponsor
- Washington University School of Medicine
- Start
- Jan 2025
- Primary completion
- Jul 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of thiotepa, carmustine in diffuse large B-cell lymphoma (DLBCL), sponsored by Washington University School of Medicine. Started Jan 2025; status: recruiting.
02
Drugs
thiotepacarmustine
03
Conditions
diffuse large B-cell lymphoma (DLBCL)
Beyond the preview
Go deeper on NCT06687772.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06687772.